SEARCH

SEARCH BY CITATION

References

  • 1
    United States Census Bureau. American community survey. Available at: http://www.census.gov/acs/www/. Accessed May 2007.
  • 2
    Centers for Disease Control and Prevention. Health disparities experienced by racial/ethnic minority populations. MMWR Morb Mortal Wkly Rep 2004; 53: 755.
  • 3
    United States Census Bureau. Census Bureau projects tripling of Hispanic and Asian populations in 50 years: non-Hispanic whites may drop to half of total population. Available at: http://www.census.gov/Press-Release/www/releases/archives/population/001720.html. Accessed September 2006.
  • 4
    Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence – SEER 17 Regs Public-Use, Nov 2005 Sub (2000-2003), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission.
  • 5
    National Center for Health Statistics. Health, United States, 2005 with Chartbook on Trends in the Health of Americans. Washington, DC: U.S. Government Printing Office; 2005;Table 31.
  • 6
    United States Cancer Statistics Working Group. United States Cancer Statistics: 2002 Incidence and Mortality. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2005;Table 1.1.1.2M.
  • 7
    Jemal A, Clegg LX, Ward E, Ries LA, Wu X, Jamison PM, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004; 101: 327.
  • 8
    Lang L. CDC points to higher prevalence of chronic HBV infection among Asian/Pacific Islanders. Gastroenterology 2006; 131: 7.
  • 9
    Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118: 30303044.
  • 10
    Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004; 38: S158S168.
  • 11
    United States Census Bureau. The foreign-born population: 2000. Available at: http://www.census.gov/prod/2003pubs/c2kbr-34.pdf. Accessed May 2007.
  • 12
    Jenkins CN, Buu C, Berger W, Son DT. Liver carcinoma prevention among Asian Pacific Islanders: getting hepatitis B shots into arms. Cancer 2001; 91: 252256.
  • 13
    Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 1981; 2: 11291133.
  • 14
    Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28: 112125.
  • 15
    World Health Organization. Hepatitis B fact sheet N°204. Available at: http://www.who.int/mediacentre/factsheets/fs204/en/. Accessed May 2007.
  • 16
    Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 6573.
  • 17
    Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004; 351: 15211531.
  • 18
    Marcellin P, Chang TT, Lim SG, Tong MJ, Sievert W, Shiffman ML, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 2003; 348: 808816.
  • 19
    Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130: 417422.
  • 20
    Hwang SJ, Tong MJ, Lai PP, Ko ES, Co RL, Chien D, et al. Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America. J Gastroenterol Hepatol 1996; 11: 949954.
  • 21
    Wright TL. Introduction to chronic hepatitis B infection. Am J Gastroenterol 2006; 101: S1S6.
    Direct Link:
  • 22
    United States Census Bureau. The Asian population: 2000. Available at: http://www.census.gov/prod/2002pubs/c2kbr01–16.pdf. Accessed May 2007.
  • 23
    United States Census Bureau. Census 2000 Summary File 2: Alameda, San Francisco, San Mateo, and Santa Clara Counties, California. Washington, DC: U.S. Department of Commerce, Economics and Statistics Administration; 2001.
  • 24
    UCLA Center for Health Policy Research, California Department of Health Services, Public Health Institute. California Health Interview Survey (CHIS) 2003. Available at: http://www.chis.ucla.edu. Accessed May 2007.
  • 25
    Daly L. Simple SAS macros for the calculation of exact binomial and Poisson confidence limits. Comput Biol Med 1992; 22: 351361.
  • 26
    Centers for Disease Control and Prevention. Screening for chronic hepatitis B among Asian/Pacific Islander populations—New York City, 2005. MMWR Morb Mortal Wkly Rep 2006; 55: 505509.
  • 27
    Guane R, Siu P, Lam K, Kim KE, Warren V, Liu H, et al. Prevalence of HBV and risk of HBV acquisition in hepatitis B screening programs in large metropolitan cities in the United States [Abstract]. HEPATOLOGY 2004; 40( Suppl): 716A.
  • 28
    Chao S, Lee PV, Prapong W, Su J, So S. High prevalence of chronic hepatitis B (HBV) infection in adult Chinese Americans living in California [Abstract]. HEPATOLOGY 2004; 40( Suppl): 717A.
  • 29
    Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy: report of a prospective study. Gastroenterology 1991; 100: 182188.
  • 30
    Kohrt HE, Ouyang DL, Keeffe EB. Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. Aliment Pharmacol Ther 2006; 24: 10031016.
  • 31
    Chen CH, Yang PM, Huang GT, Lee HS, Sung JL, Sheu JC. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc 2007; 106: 145155.
  • 32
    Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsay SH, et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. HEPATOLOGY 1998; 28: 231236.
  • 33
    Chen YC, Sheen IS, Chu CM, Liaw YF. Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology 2002; 123: 10841089.
  • 34
    Su FH, Chen JD, Cheng SH, Lin CH, Liu YH, Chu FY. Seroprevalence of hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national hepatitis-B vaccination program. J Med Virol 2007; 79: 138143.
  • 35
    Fitzsimons D, Francois G, Hall A, McMahon B, Meheus A, Zanetti A, et al. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine 2005; 23: 41584166.
  • 36
    Taylor VM, Tu SP, Woodall E, Acorda E, Chen H, Choe J, et al. Hepatitis B knowledge and practices among Chinese immigrants to the United States. Asian Pac J Cancer Prev 2006; 7: 313317.
  • 37
    Taylor VM, Jackson JC, Chan N, Kuniyuki A, Yasui Y. Hepatitis B knowledge and practices among Cambodian American women in Seattle, Washington. J Community Health 2002; 27: 151163.
  • 38
    Thompson MJ, Taylor VM, Jackson JC, Yasui Y, Kuniyuki A, Tu SP, et al. Hepatitis B knowledge and practices among Chinese American women in Seattle, Washington. J Cancer Educ 2002; 17: 222226.
  • 39
    Taylor VM, Choe JH, Yasui Y, Li L, Burke N, Jackson JC. Hepatitis B awareness, testing, and knowledge among Vietnamese American men and women. J Community Health 2005; 30: 477490.
  • 40
    Prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen. MMWR Morb Mortal Wkly Rep 1988; 37: 341346, 351.
  • 41
    Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1991; 40: 125.
  • 42
    Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005; 54: 131.
  • 43
    Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006; 55: 133.